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Commentary
Constituting  as  many  as  10%  of  cells  in  the  central 
nervous system (CNS), microglia are a subset of glial cells 
whose function is a longstanding mystery. Unlike other 
glial cells - the astrocytes and oligodendrocytes - micro-
glia  derive  from  cells  of  the  immune  system.  As  such, 
they act as first responders to direct CNS damage and 
peripheral  insults,  a  response  characterized  by  rapid 
hypertrophy of their long fine cell processes, upregulation 
of cytokine and surface receptor expression, and increased 
phagocytosis [1]. The morphological changes associated 
with their transformation from ramified ‘resting’ micro-
glia to ameboid ‘activated’ microglia were reported in the 
19th century based on observations of CNS tissue infected 
with  rabies  virus,  from  a  deceased  multiple  sclerosis 
patient, and later in neurodegenerative diseases [2]. Since 
then, many studies have focused on the importance of 
activated microglia in health and disease. The function of 
ramified  microglia,  however,  remains  elusive.  Two 
photon in vivo imaging reveals that fluorescently labeled 
ramified microglia constantly extend and retract processes, 
preferentially contacting synapses in an activity-dependent 
manner [3]. Following these studies, many have called for 
rebranding ‘resting’ microglia as ‘monitoring’ microglia 
or some more descriptive appellation in keeping with our 
increasing understanding of what they do. A recent study 
by  Knut  Biber  and  colleagues  in  the  Journal  of 
Neuroinflammation now significantly furthers our grasp 
of microglial function by demonstrating a neuro  protec-
tive  role  of  microglia  in  N-methyl-D-aspartic  acid 
(NMDA)-induced excitotoxicity [4].
NMDA receptors are a subset of glutamate receptors, 
which can lead to neuronal excitation; too much gluta-
mate, such as after CNS damage, can promote excessive 
excitation  and  become  toxic.  Treatment  of  mouse 
organo  typic hippocampal slice cultures with micromolar 
amounts  of  NMDA  induces  neuronal  cell  death  in  a 
region-specific manner. Neurons of the CA1 region are 
most  susceptible  to  NMDA-induced  toxicity,  whereas 
neurons  in  CA3  and  dentate  gyrus  (DG)  are  less 
vulnerable. The reason for this differential vulnerability is 
unclear, although Vinet et al. [4] noticed that there are 
more  morphologically  activated  microglia  within  CA1, 
an area of high neuronal death, compared with CA3 and 
DG (Figure 1). To determine the effect of microglia on 
NMDA-dependent neurotoxicity, they ablated microglia 
within hippocampal slices using two methods - clodronate 
liposomes  and  a  genetically  encoded  thymidine  kinase 
that induces apoptosis of proliferating cells upon gancyc-
lovir treatment - and assessed the level of neuronal cell 
death. Surprisingly, loss of microglia exacerbated NMDA-
induced toxicity, abolishing the differential vulnerability 
of neurons in hippocampal subregions at some NMDA 
doses. These data suggested a neuroprotective function 
of  microglia.  The  researchers  tested  this  possibility  by 
reseeding microglia-depleted slices with primary micro-
glia from mixed glial cultures before NMDA treatment. 
These  microglia  successfully  engrafted,  exhibiting 
branch  ing, fine processes similar to ramified microglia in 
the  healthy  CNS.  Remarkably,  repletion  of  microglia 
resulted  in  significant  neuroprotection  compared  with 
slice cultures maintained without microglia.
Abstract
Microglia are the abundant, resident myeloid cells of 
the central nervous system (CNS) that become rapidly 
activated in response to injury or inflammation. While 
most studies of microglia focus on this phenomenon, 
little is known about the function of ‘resting’ microglia, 
which possess fine, branching cellular processes. 
Biber and colleagues, in a recent paper in Journal of 
Neuroinflammation, report that ramified microglia 
can limit excitotoxicity, an important insight for 
understanding mechanisms that limit neuron death in 
CNS disease.
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tion of microglia in NMDA-induced excitotoxicity and 
suggests that ramified microglia may contribute to this 
neuroprotection.  The  findings  raise  several  important 
questions. First, what is the relationship between micro-
glial  morphology  and  function?  While  much  is  known 
about  stimuli  that  promote  microglial  activation,  rela-
tively little is understood about the function and mecha-
nism of the ramified morphology. The CNS milieu likely 
contributes,  as  bone  marrow-derived  monocytes  co-
cultured with astrocytes adopt a ramified, microglia-like 
appearance  [5].  In  addition,  disruption  of  microglia-
neuron interactions, such as those mediated by the cell 
surface protein CD200 on neurons and its receptor on 
microglia, results in abnormal microglial morphology [6]. 
Importantly, donor-derived monocytes infiltrate the CNS 
following  bone  marrow  transplantation  and  eventually 
adopt a ramified, microglia-like morphology [7]. However, 
can  such  blood-derived  cells  truly  become  microglia? 
During  development  microglia  derive  from  primitive 
macro  phages  that  enter  the  developing  neural  tube 
during  early  embroygenesis  and,  except  in  injury  like 
irradiation  for  bone  marrow  transplantation,  are  not 
replaced by infiltrating bone marrow-derived monocytes 
[7]. In addition, increasing evidence suggests divergent 
functions for these cell types in mouse models of disease. 
To fully appreciate the mysterious function of microglia 
in  health  and  disease,  a  better  understanding  of  the 
relationship  between  microglial  morphology  and  func-
tion is needed.
Second,  what  is  the  precise  mechanism  by  which 
microglia confer protection from NMDA-induced excito-
toxicity? Vinet et al. [4] report that ramified microglia 
contribute to reduced neurotoxicity based on the obser-
vations that ramified microglia appear in less vulnerable 
hippocampal  regions  and  that  replenished  microglia 
prevent excitotoxicity and eventually become ramified. It 
is also possible that these microglia - which by virtue of 
the culture conditions become activated - release neuro-
protective factors. Alternatively, microglia may secrete as 
yet unidentified NMDA antagonists or secrete cytokines 
that regulate NMDA receptor function or density. In fact, 
TNFalpha, a cytokine produced exclusively by microglia 
and macrophages within the brain, has previously been 
Figure 1.	Differential susceptibility of hippocampal subregions to NMDA-induced excitotoxicity is correlated with microglial morphology. 
CA1 neurons (red) are most vulnerable to excitotoxicity, compared with CA3 and dentate gyrus (DG) neurons (blue). In response to NMDA 
challenge, microglia within CA1 adopt an activated morphology, whilst microglia within protected regions retain a ramified appearance (insets).
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gluta  mate  receptors  called  AMPA  receptors  [8]. 
Addition  ally, Biber’s group previously reported that the 
chemokine CXCL10 produced by astrocytes may mediate 
NMDA-induced  neurotoxicity  via  CXCR3  signaling  in 
microglia [9]. It is possible that microglia signal to nearby 
astrocytes  to  control  their  levels  of  glutamate  uptake 
transporters. Whatever the mechanism, the finding that 
microglia  powerfully  control  excitotoxicity  provides  an 
important clue for future studies aimed at understanding 
the  molecular  mechanisms  that  control  excitotoxicity 
and how neurons can be better protected in various acute 
and chronic neurological diseases.
A final critical question raised by the experiments of 
Vinet et al. is whether this type of microglia-mediated 
neuroprotection  occurs  in  vivo.  Resident  cells  of  the 
intact  CNS  are  not  exposed  to  serum.  Gene  profiling 
experiments by our lab demonstrate that serum exposure 
in  culture  can  induce  gene  expression  changes  in 
astrocytes that mimic those of activated astrocytes [10]. 
Many  components  of  serum  are  known  modulators  of 
microglial  activation  [2].  In  addition,  culture  in  serum 
often requires non-physiological drug dosages, making in 
vivo translation difficult. While organotypic hippocampal 
slice cultures have proven extremely valuable in under-
standing fundamental mechanisms underlying glutamate 
excitotoxicity, in vivo investigation is required to sort out 
the  physiological  relevance  of  these  processes  in  a 
developing, mature, or injured CNS. Recent advances in 
imaging  technologies,  transplantation  experiments  and 
genetic ablation have improved our understanding of the 
importance of microglia in health and disease. However, 
development  of  new  tools  to  specifically  manipulate 
microglia in vivo is now essential for continued discovery 
and innovation in microglial research.
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